Literature DB >> 12388336

Characterization of CD34+ cells isolated from human fetal lung.

Michael J Acarregui1, Katherine M England, Joshua T Richman, Jennifer L Littig.   

Abstract

The large capillary mass of the newborn lung demands the presence of endothelial cell precursors in lung tissue before development of the pulmonary capillary bed. The objective of this investigation was to isolate and characterize putative endothelial cell precursors from developing human lung. CD34, a cell surface marker for hematopoietic progenitor cells, endothelial precursor cells, and small vessel endothelial cells, was employed as an immunological "handle" for the selection of the desired cells. When CD34+ cells were isolated from midtrimester human fetal lung tissue, then maintained in culture, the isolated cells expressed immunoreactivity for the endothelial cell marker von Willebrand factor and the vascular endothelial growth factor receptors KDR and Flt-1. However, only 5% or fewer of the cells expressed PECAM, an important factor in cell-cell interactions and a marker for endothelial cells associated with vessels. The CD34+ cells endocytosed acetylated low-density lipoprotein and formed capillary-like structures when incubated in a cushion of Matrigel. RT-PCR analysis of mRNA for endothelial cell-related proteins Flt-1, Tie-2, and endothelial nitric oxide synthase demonstrated expression of these mRNAs by the isolated cells for at least 16 cell passages. These observations demonstrate that capillary endothelial cell precursors can be isolated from developing human lung and maintained in cell culture. These cells represent a potentially important tool for investigating the regulation of mechanisms governing development of the air-blood barrier in the human lung.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388336     DOI: 10.1152/ajplung.00202.2002

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  CD34-positive developing vessels and other structures in human fetuses: an immunohistochemical study.

Authors:  Shin-ichi Abe; Masashi Suzuki; Kwang Ho Cho; Gen Murakami; Baik Hwan Cho; Yoshinobu Ide
Journal:  Surg Radiol Anat       Date:  2011-07-26       Impact factor: 1.246

2.  Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor.

Authors:  Su Jin Cho; Caroline L S George; Jeanne M Snyder; Michael J Acarregui
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-01       Impact factor: 6.914

3.  Preferential activity of Tie2 promoter in arteriolar endothelium.

Authors:  Mirela Anghelina; Leni Moldovan; Nicanor I Moldovan
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

4.  Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.

Authors:  Y Bertrand; J-C Currie; J Poirier; M Demeule; A Abulrob; D Fatehi; D Stanimirovic; H Sartelet; J-P Castaigne; R Béliveau
Journal:  Br J Cancer       Date:  2011-10-25       Impact factor: 7.640

5.  Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.

Authors:  Ying Li; Xuemin Zheng; Min Gong; Jianning Zhang
Journal:  Oncotarget       Date:  2016-11-29

6.  Transport characteristics of a novel peptide platform for CNS therapeutics.

Authors:  Yanick Bertrand; Jean-Christophe Currie; Michel Demeule; Anthony Régina; Christian Ché; Abedelnasser Abulrob; Dorothy Fatehi; Hervé Sartelet; Reinhard Gabathuler; Jean-Paul Castaigne; Danica Stanimirovic; Richard Béliveau
Journal:  J Cell Mol Med       Date:  2010-12       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.